Physicochemical stability of lipid injectable emulsions: correlating changes in large globule distributions with phase separation behavior

T Gonyon, P Patel, H Owen, AJ Dunham… - International journal of …, 2007 - Elsevier
Single particle optical sensing (SPOS) and visual inspection were used to characterize a
series of lipid injectable emulsions (n=21) featuring three lipid types, two electrolyte conditions, …

Interactions between parenteral lipid emulsions and container surfaces

T Gonyon, AE Tomaso, P Kotha, H Owen… - PDA Journal of …, 2013 - journal.pda.org
Objective: To evaluate the relationship between changes in emulsion globule size distributions
and container uptake of lipid emulsions in total nutrient admixtures. Methods: A total …

Physicochemical stability of phospholipid-dispersed suspensions of crystalline itraconazole

J Werling, S Graham, H Owen, L Nair, T Gonyon… - European journal of …, 2008 - Elsevier
The physicochemical stability of an aqueous, phospholipid-based dispersion of itraconazole
microcrystals was studied as a model water-insoluble drug suspension. The particle size, …

Container effects on the physicochemical properties of parenteral lipid emulsions

T Gonyon, PW Carter, O Dahlem, AR Denet, H Owen… - Nutrition, 2008 - Elsevier
OBJECTIVE: We evaluated the effects of glass and plastic containers on the physicochemical
properties of parenteral nutrition lipid emulsions and total nutrient admixtures with an …

Probability‐Based Compatibility Curves for Calcium and Phosphates in Parenteral Nutrition Formulations

T Gonyon, PW Carter, G Phillips… - Journal of Parenteral …, 2014 - Wiley Online Library
Background: The information content of the calcium phosphate compatibility curves for adult
parenteral nutrition (PN) solutions may benefit from a more sophisticated statistical treatment…

Calcium/phosphate solubility curves for Premasol and Trophamine pediatric parenteral nutrition formulations

HJ Owen, TM Gonyon, JBD Green… - The Journal of …, 2019 - meridian.allenpress.com
OBJECTIVES Calcium and phosphate incompatibility in parenteral nutrition formulations
remains a critical concern for patient safety. This study examined calcium phosphate solubility …

Conformance with USP chapter 729 for parenteral nutritional emulsions

T Gonyon, PW Carter, JL Trouilly - American Journal of Health …, 2008 - academic.oup.com
The United States Pharmacopeia (USP) recently approved general information chapter 729,
which specifies limits for the lipid globule size distribution (GSD) of parenteral nutritional …

[HTML][HTML] Automated system for kinetic analysis of particle size distributions for pharmaceutically relevant systems

…, Y Zhang, D Patel, P Kotha, T Gonyon - Journal of Analytical …, 2014 - hindawi.com
Detailing the kinetics of particle formation for pharmaceutically relevant solutions is
challenging, especially when considering the combination of formulations, containers, and …

[CITATION][C] Safety and stability of lipid emulsions

GP Zaloga, AJ Dunham, TM Gonyon… - Nutrition in Clinical …, 2007 - Wiley Online Library
“Lipid Injectable Emulsions: 2006.” 1 The article addresses 3 very important issues related
to lipid emulsions: clinical safety, characterization of lipid emulsions using globule size …

Potency of n-3 PUFA anti-inflammatory effects on human and rodent immune cell responses (111.16)

D Kasprowicz, S Ravindran Nair, T Gonyon… - The Journal of …, 2011 - journals.aai.org
Pharmaceutical parenteral emulsions consisting of n-6 poly-unsaturated fatty acids (PUFAs)
alone (Intralipid®), n-6 PUFAs and n-9 mono-unsaturated fatty acids (MUFAs; eg Clinoleic®)…